Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Learn about the various fees that may come with cash back credit cards. Equip yourself with this knowledge before applying.
22,981 articlesTeva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Could Apple defy a mid-year lull and spark a second-half rally in 2026? This article breaks down the catalysts, risks...
Joby Aviation is transitioning from test flights to revenue growth, with 2026 guidance anchoring the stock as investo...
A domestic uranium producer is expanding beyond ore to processing key minerals. This article breaks down the strategy...
On July 1, Meta Platforms lit up the market with a 9% jump that pushed the stock toward $612.91. The move followed re...
Apple pushes to a fresh all-time high as AI-enabled products and a robust services ecosystem drive growth. The move w...
AMC stunned traders with a profitability surprise that sent its shares higher. This piece breaks down the catalysts, ...
Alphabet has quietly been reshaping the AI race. This article breaks down which segment is growing fastest, why it ma...
A solid move by a seasoned fund—Alpine Capital Research increases its Arrow Electronics position. Learn what this cou...
A major fund trimmed its LKQ position by 777,000 shares, raising questions about what this means for the stock and th...
Alcoa reports strong 2025 cash flow and earnings while planning to monetize smelting assets, set against a cooling en...
Netflix charts a high-stakes path, slowing buybacks to fund a debt-heavy growth plan and weighing a marquee deal, as ...